C103H140N6O29S2Si2 — CID 90828396
(6aS)-3-hydroxy-2-methoxy-8-methylidene-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-11-one;2-[3-[3,5-bis[[tert-butyl(dimethyl)silyl]oxymethyl]phenyl]propoxy]ethyl methyl carbonate;[3-[3-(2-methoxycarbonyloxyethoxy)propyl]-5-(methylsulfonyloxymethyl)phenyl]methyl methanesulfonate;methyl 3-[2-[3-[3,5-bis[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenyl]propoxy]ethoxy]propanoate (PubChem CID 90828396) has the molecular formula C103H140N6O29S2Si2 and a molecular weight of 2046.57 g/mol. Its IUPAC name is (6aS)-3-hydroxy-2-methoxy-8-methylidene-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-11-one;2-[3-[3,5-bis[[tert-butyl(dimethyl)silyl]oxymethyl]phenyl]propoxy]ethyl methyl carbonate;[3-[3-(2-methoxycarbonyloxyethoxy)propyl]-5-(methylsulfonyloxymethyl)phenyl]methyl methanesulfonate;methyl 3-[2-[3-[3,5-bis[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenyl]propoxy]ethoxy]propanoate.
| Compound Name | (6aS)-3-hydroxy-2-methoxy-8-methylidene-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-11-one;2-[3-[3,5-bis[[tert-butyl(dimethyl)silyl]oxymethyl]phenyl]propoxy]ethyl methyl carbonate;[3-[3-(2-methoxycarbonyloxyethoxy)propyl]-5-(methylsulfonyloxymethyl)phenyl]methyl methanesulfonate;methyl 3-[2-[3-[3,5-bis[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenyl]propoxy]ethoxy]propanoate |
|---|---|
| PubChem CID | 90828396 |
| Molecular Formula | C103H140N6O29S2Si2 |
| Molecular Weight | 2046.57 g/mol |
| Exact Mass | 2044.86 |
| IUPAC Name | (6aS)-3-hydroxy-2-methoxy-8-methylidene-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-11-one;2-[3-[3,5-bis[[tert-butyl(dimethyl)silyl]oxymethyl]phenyl]propoxy]ethyl methyl carbonate;[3-[3-(2-methoxycarbonyloxyethoxy)propyl]-5-(methylsulfonyloxymethyl)phenyl]methyl methanesulfonate;methyl 3-[2-[3-[3,5-bis[[(6aS)-2-methoxy-8-methylidene-11-oxo-7,9-dihydro-6aH-pyrrolo[2,1-c][1,4]benzodiazepin-3-yl]oxymethyl]phenyl]propoxy]ethoxy]propanoate |
| SMILES | C=C1C[C@H]2C=Nc3cc(O)c(OC)cc3C(=O)N2C1.C=C1C[C@H]2C=Nc3cc(OCc4cc(CCCOCCOCCC(=O)OC)cc(COc5cc6c(cc5OC)C(=O)N5CC(=C)C[C@H]5C=N6)c4)c(OC)cc3C(=O)N2C1.COC(=O)OCCOCCCc1cc(COS(C)(=O)=O)cc(COS(C)(=O)=O)c1.COC(=O)OCCOCCCc1cc(CO[Si](C)(C)C(C)(C)C)cc(CO[Si](C)(C)C(C)(C)C)c1 |
| InChI | InChI=1S/C45H50N4O10.C27H50O6Si2.C17H26O10S2.C14H14N2O3/c1-28-13-33-22-46-37-20-41(39(53-3)18-35(37)44(51)48(33)24-28)58-26-31-15-30(7-6-9-56-11-12-57-10-8-43(50)55-5)16-32(17-31)27-59-42-21-38-36(19-40(42)54-4)45(52)49-25-29(2)14-34(49)23-47-38;1-26(2,3)34(8,9)32-20-23-17-22(13-12-14-30-15-16-31-25(28)29-7)18-24(19-23)21-33-35(10,11)27(4,5)6;1-23-17(18)25-8-7-24-6-4-5-14-9-15(12-26-28(2,19)20)11-16(10-14)13-27-29(3,21)22;1-8-3-9-6-15-11-5-12(17)13(19-2)4-10(11)14(18)16(9)7-8/h15-23,33-34H,1-2,6-14,24-27H2,3-5H3;17-19H,12-16,20-21H2,1-11H3;9-11H,4-8,12-13H2,1-3H3;4-6,9,17H,1,3,7H2,2H3/t33-,34-;;;9-/m0..0/s1 |
| InChIKey | BPXACSMOTUZKRF-GVVAFYLESA-N |
| XLogP | 17.08 |
| TPSA | 403.87 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 32 |
| Rotatable Bonds | 45 |
| Heavy Atoms | 142 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2046.57 |
| LogP ≤ 5 | 17.08 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 32 |
| Structural Alerts | {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Sulfonic_acid_1', 'substructure': 'N/A'} |
|---|